If you haven't already listened to Gerald Smith on the interview, you should take the time. Some very interesting facts in there, and approximately double money of already announced will be announced shortly. Money problems are behind them for sure. Anyways, I think it was very well done.
Viragen Chairman Interviewed by Wall Street Reporter.com And Wall Street Transcript.com
PLANTATION, Fla., March 10 /PRNewswire/ -- Viragen, Inc. (OTC Bulletin Board: VRGN) announced that Chairman and CEO, Gerald Smith, was interviewed
today by the Wall Street Reporter and recently by the Wall Street Transcript. These interviews can be accessed on the Internet at wallstreetreporter.com until
Friday, March 17, 2000 and wallstreettranscript.com currently.
Viragen is an emerging biopharmaceutical company engaged in the research and development of immunomodulatory therapeutic products, including natural alpha
interferon and human monoclonal antibodies, for the treatment of various diseases and immune disorders.
Investor Relations Contact: Michael Brod, Cameron Associates, Inc.; Phone: (212) 245-8800; Fax (212) 245-4165; E-mail: michael@cameronassoc.com.
Corporate Contact: Mel Rothberg, Executive Vice President; Phone: (954) 233-8746; Fax (954) 233-8743; E-mail: mrothberg@viragen.com.
This release contains forward-looking statements that are subject to risks and uncertainties, including but not limited to, certain delays beyond the Company's control
with respect to future business events, regulatory approvals and other risks detailed from time to time in the Company's filings with the Securities and Exchange
Commission.
For more information, please visit the web site at: viragen.com . |
